Both in Surgical Instruments
Treace Medical Concepts vs Embecta
Over the past year TMCI returned −30.7% and EMBC returned −53.1%; their daily moves had a correlation of 0.09.
TMCI −30.7% EMBC −53.1%Growth of $1, one year, split-adjusted
| Metric | TMCI | EMBC |
|---|---|---|
| Price | $4.43 | $6.25 |
| Market cap | $288.1M | $354.1M |
| Today | −12.45% | −4.73% |
| 1 month | +2.3% | +7.9% |
| 6 months | +138.2% | −32.3% |
| Year to date | +80.8% | −47.4% |
| 1 year | −32.4% | −54.0% |
| Revenue growth (YoY) | −4.2% | −8.1% |
| Gross margin | 78.5% | 56.4% |
| Net margin | −35.0% | 7.8% |
| P/E (TTM) | — | 4.0× |
| Price / sales | 1.4× | 0.3× |
| Net cash | -$10.4M | -$1.27B |
| Dividend yield | — | 0.64% |
| Volatility (60d) | 62.3% | 73.0% |
| Short % of float | 4.0% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).